Journal profile · ENDOCRINOLOGY & METABOLISM
Journal of Endocrinology Metabolism and Diabetes of South Africa
ISSN 1608-9677 · eISSN 2220-1009 · Medpharm Publications · South Africa
Journal of Endocrinology Metabolism and Diabetes of South Africa: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 0.6 (journal website); fully open access; APC about USD 1,590; median 184 days to acceptance (19 articles, last 24 months); acceptance rate 61% (journal website); 15 articles in 2025; indexed in ESCI.
Scope
Aims, scope and focus
Journal of Endocrinology Metabolism and Diabetes of South Africa is published by Medpharm Publications and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Diabetes, Cardiovascular Risks, and Lipoproteins, Diabetes Management and Research and Diabetes Management and Education, together about 35.2% of its articles. Its main subfields are Endocrinology, Diabetes and Metabolism. (generated from OpenAlex topic counts and CAS ranking data)
Focus and Scope The Journal of Endocrinology, Metabolism and Diabetes of South Africa (JEMDSA) is a peer reviewed, medical journal that focuses on Endocrinology, Metabolism and Diabetes. It carries research articles and letters, editorials, clinical practice and other medical articles and personal opinion, South African health-related news, obituaries, general correspondence, and classified advertisements JEMDSA representation JEMDSA is the official journal of SEMDSA (Society for Endocrinology, Metabolism and Diabetes of South Africa), DESSA (Diabetes Education Society of South Africa), NOFSA (National Osteoporosis Foundation of South Africa), SASOM (South African Society of Obesity and Metabolism), LASSA (Lipid and Atherosclerosis Society of South Africa) and PAEDS-SA (The Paediatric and Adolescent Endocrine and Diabetes Society of South Africa). SEMDSA has for many years strived to be an umbrella organisation for affiliated South African professional societies with a focus and scope in advancing research and education in the fields of endocrinology, metabolism and diabetes. Vision of the journal JEMDSA aims to publish world-class scholarly work in endocrinology, metabolism and diabetes. The journal is accredited by the National Department of Education for the measurement of research output of public higher education institutions and earns research subsidies for South African academic departments. Through stringent peer review, the journal also aims to make a regional contribution to the international knowledge base of endocrinology, metabolism and diabetes and hopes to also offer other African countries the opportunity to make a world-class African contribution. Through strategic indexing and compliance with larger databases of world class medical research, JEMDSA aims to eventually be indexed in larger indexes such as Index Copernicus, Biosis, EMBASE, Medline and ISI. The journal further aims to provide a platform for clinical reviews and debate on practical and controversial issues in endocrinology, metabolism and diabetes. The journal aims to be instrumental in publishing and revising therapeutic protocols and national guidelines. Reviews will also be invited to address pertinent clinical and therapeutic issues for its practising readership. The print run of the journal is 2 000 and comprises the members of the various societies, namely general physicians, endocrinologists, diabetologists, diabetes nurse educators, lipidologists, beriatricians, paedia
From the journal's Aims & Scope
Research area (LetPub): ENDOCRINOLOGY & METABOLISM
Editor-in-chief Joel DavePublisher website
Editorial board by country: none in mainland China; most named South Africa 5 (5 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Diabetes, Cardiovascular Risks, and LipoproteinsMedicine15%
- Diabetes Management and ResearchMedicine11.6%
- Diabetes Management and EducationMedicine8.7%
- Chronic Disease Management StrategiesMedicine5.3%
- Bone health and osteoporosis researchMedicine4.7%
- Diabetes and associated disordersBiochemistry, Genetics and Molecular Biology4.7%
- Hormonal Regulation and HypertensionMedicine4%
- Hyperglycemia and glycemic control in critically ill and hospitalized patientsMedicine3.7%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Endocrinology & Metabolism | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Endocrinology & Metabolism | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
ESCIDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
MEDLINEEmbasePublisher website
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor (publisher) 2025
- 0.6Publisher website ·
- 5-year impact factor (publisher) 2025
- 0.6Publisher website ·
- h-index
- 25OpenAlex ·
- i10-index
- 78OpenAlex ·
- 2-year mean citedness
- 0.56OpenAlex ·
- Self-citation rate
- 16.7%LetPub ·
- Share of gold OA articles
- 100%LetPub ·
Volume
- Articles per year
- 16LetPub ·
- Downloads per year (publisher)
- 51,000Publisher website ·
Articles by year OpenAlex count · 452 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 14 | 14 | 0 |
| 2025 | 15 | 15 | 4 |
| 2024 | 12 | 12 | 19 |
| 2023 | 13 | 13 | 17 |
| 2022 | 18 | 18 | 52 |
| 2021 | 22 | 22 | 118 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
184 daysMedian, submission to acceptance · P25–P75 96 days – 209 days
- Acceptance to online
- median 40 days (20 articles)
- Submission to online
- median 220 days
- Sample
- 19 articles with submission and acceptance dates (28 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 7 weeksLetPub ·
- Acceptance rate (publisher)
- 61%Publisher website ·
- Submission to first decision
- 47 daysPublisher website ·
- First decision after review
- 55 daysPublisher website ·
- Submission to publication (journal-reported)
- about 7 weeksDOAJ ·
- Peer review
- Double anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | USD 1,590 | Yes | CC BY-NC | |
| OpenAlex | USD 1,590 | — | — | |
| LetPub | USD 1,590 | Yes | — | |
| Publisher website | USD 1,590 | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Article types accepted3
- case reportCase Report | Published online: 25 Aug 2026Length not stated
- research articleResearch Article | Published online: 19 Aug 2026Length not stated
- review articleReview Article | Published online: 19 Aug 2026Length not stated
Policy excerpts from the journal's websiteOpen access
- Open access Open access
Journal of Endocrinology, Metabolism and Diabetes of South Africa is an open access journal and only publishes open access articles. Publishing open access means that your article will be free to access online immediately on publication, increasing the visibility, readership, and impact of your research. Why choose open access? Increase the discoverability and readership of your article Make an im…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Medpharm Publications
- Country or region
- South Africa
- Language
- English
- ISSN
- 1608-9677
- Electronic ISSN
- 2220-1009
- Society / sponsor
- Society for Endocrinology Metabolism and Diabetes of South Africa
- Latest issue on the website
- Volume 31, Issue 2 (2026)
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗LetPub
- Editorial board ↗LetPub
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Journal of Endocrinology Metabolism and Diabetes of South Africa
What CAS zone is Journal of Endocrinology Metabolism and Diabetes of South Africa in?
In the 2025 upgraded edition of the CAS Journal Ranking, Journal of Endocrinology Metabolism and Diabetes of South Africa is in Zone 4 of Medicine, and in Zone 4 of the minor category Endocrinology & Metabolism. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Journal of Endocrinology Metabolism and Diabetes of South Africa?
The journal's website gives an impact factor of 0.6 (2025); this is the journal's own figure, as LetPub lists none for it; h-index 25.
How long does peer review take at Journal of Endocrinology Metabolism and Diabetes of South Africa?
Based on the dates recorded on 19 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 184 days (interquartile range 96–209 days); authors report an average review time of about 7 weeks; the journal's website gives an acceptance rate of 61%. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Where are the editorial board members of Journal of Endocrinology Metabolism and Diabetes of South Africa based?
Of the 5 board members whose country the journal's board page names, none are in mainland China; the countries named most often are South Africa (5). Counted from the institutions listed on the board page; for reference only.
Which databases index Journal of Endocrinology Metabolism and Diabetes of South Africa?
According to LetPub and DOAJ records, Journal of Endocrinology Metabolism and Diabetes of South Africa is indexed in ESCI and DOAJ. The journal's website also lists MEDLINE and Embase; that list has not been checked against each database.
Is Journal of Endocrinology Metabolism and Diabetes of South Africa open access, and what is the APC?
Journal of Endocrinology Metabolism and Diabetes of South Africa is a fully open-access journal. APC about USD 1,590.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-30). Last updated: .